These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 877166)

  • 1. [Hemostatic processes in aneurysmal hemorrhages].
    Hindersin P; Heidrich R
    Psychiatr Neurol Med Psychol (Leipz); 1977 Mar; 29(3):129-44. PubMed ID: 877166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current status of intrathecal antifibrinolytic therapy with p-aminomethylbenzoic acid (PAMBA) in subarachnoid hemorrhages].
    Hindersin P; Endler S; Heidrich R; Lehmann W; Dietrich J
    Psychiatr Neurol Med Psychol (Leipz); 1985 Dec; 37(12):686-9. PubMed ID: 3879362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptokinase clot lysis time in patients with ruptured intracranial aneurysms.
    Geronemus R; Herz DA; Shulman K
    J Neurosurg; 1974 Apr; 40(4):499-503. PubMed ID: 4814382
    [No Abstract]   [Full Text] [Related]  

  • 5. [Disturbances of the hemostatic system in patients with aneurysmal subarachnoid hemorrhage].
    Baranich AI; Savin IA; Tabasaranskiy TF; Polupan AA; Sychev AA; Kurdyumova NV; Pilipenko YV; Mikeladze KG; Eliava SS
    Zh Vopr Neirokhir Im N N Burdenko; 2018; 82(4):109-116. PubMed ID: 30137045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prediction of recurrent hemorrhages from ruptured arterial aneurysms in the acute period].
    Lebedev VV; Kholodov SA; Platonova TK; Shelkovskiĭ VN; Krylov VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(9):1281-4. PubMed ID: 3776404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of tranexamic acid on bleeding time and haemostasis.
    Menzies SA; Hartley JA; Hitchcock ER; Rorke E; Gill JS
    Neurochirurgia (Stuttg); 1991 Sep; 34(5):141-3. PubMed ID: 1745318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coagulation physiological controls in subarachnoid hemorrhages and their therapeutic implications].
    Hindersin P; Endler S; Heidrich R
    Psychiatr Neurol Med Psychol (Leipz); 1982 Apr; 34(4):236-41. PubMed ID: 7100333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.
    Vergouwen MD; Meijers JC; Geskus RB; Coert BA; Horn J; Stroes ES; van der Poll T; Vermeulen M; Roos YB
    J Cereb Blood Flow Metab; 2009 Aug; 29(8):1444-53. PubMed ID: 19458605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring antifibrinolytic therapy in subarachnoid hemorrhage.
    Smith RR; Upchurch JJ
    J Neurosurg; 1973 Mar; 38(3):339-44. PubMed ID: 4268202
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinolytic activity of cerebrospinal fluid as an indicator of the risk of repeated ruptures of arterial aneurysms].
    Kholodov SA; Shelkovskiĭ VN; Platonova TK
    Zh Vopr Neirokhir Im N N Burdenko; 1985; (4):18-22. PubMed ID: 4050242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of early rebleeding.
    Roos Y; Vermeulen M
    J Neurosurg; 2003 May; 98(5):1148-9; author reply 1149-50. PubMed ID: 12744388
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrinolytic activity of cerebrospinal fluid in subarachnoid hemorrhage (author's transl)].
    Imanaga H; Osugi T; Kagawa M; Kita-Mura K
    No Shinkei Geka; 1977 Jan; 5(1):51-8. PubMed ID: 557178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition.
    Burchiel KJ; Hoffman JM; Bakay RA
    Neurosurgery; 1984 Jan; 14(1):57-63. PubMed ID: 6537999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coagulation-fibrinolysis abnormalities in acute stage of subarachnoid hemorrhage (Part 1)--With special reference to the relation between cerebral vasospasm and fibrinopeptides A and B beta].
    Touho H; Hino A; Suzuki K; Kubo T; Hirakawa K
    No To Shinkei; 1984 Oct; 36(10):1009-14. PubMed ID: 6518124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of early rebleeding.
    Schisano G; Nina P
    J Neurosurg; 2003 May; 98(5):1147-8; author reply 1148. PubMed ID: 12744387
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of early rebleeding.
    Iplikçioglu AC; Bek S
    J Neurosurg; 2003 May; 98(5):1147; author reply 1148. PubMed ID: 12744386
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation and management of aneurysmal subarachnoid hemorrhage.
    Lasner TM; Raps EC
    Neuroimaging Clin N Am; 1997 Nov; 7(4):669-78. PubMed ID: 9336492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemostasis in cerebrospinal fluid. Basic concept of antifibrinolytic therapy of subarachnoid haemorrhage.
    Hindersin P; Heidrich R; Endler S
    Acta Neurochir Suppl (Wien); 1984; 34():1-77. PubMed ID: 6395643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of an intravenous injection of nicardipine on cerebral blood flow in subarachnoid hemorrhage caused by intracranial aneurysm].
    Montarry M; Chacornac R; Philippon B; Bouchet C; Guichard P
    Agressologie; 1989 Jun; 30(7):411-5. PubMed ID: 2817238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.